FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

758731000168106: Chelsea-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 3 x 28 tablets, blister packs (containered trade product pack)


Status: current, Defined. Date: 29-Feb 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1536501000168112 Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs en Synonym Active Case sensitive Australian Medicines Terminology module
4136951000168119 Chelsea-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 3 x 28 tablets, blister packs (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4145121000168119 Chelsea-35 ED (cyproterone acetate 2 mg + ethinyloestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 3 x 28 tablets, blister packs en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs Is a containered trade product pack true Inferred relationship Some
Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs Is a Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 true Inferred relationship Some
Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs has TPUU Chelsea-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet true Inferred relationship Some 2
Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs has TPUU Chelsea-35 ED (inert substance) tablet true Inferred relationship Some 3
Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs has subpack Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28, blister pack true Inferred relationship Some 1
Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs has container type blister pack true Inferred relationship Some
Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs has TP Chelsea-35 ED true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start